CPC, the pet crematorium, has developed a new online survey tool to help practice staff analyse the effectiveness of their bereavement care capabilities.
Called "Bereavement Care - How does your practice compare?", the online survey comprises a series of multiple choice questions designed to produce a star rating out of 5. The idea is that these questions will help practices establish whether they need to improve how staff deal with bereaved pet owners.
Duncan Francis, Director, CPC said: "Coping with the loss of a much-loved pet is never easy for a bereaved owner. While support from those who are close to both the owner and the pet can make a real difference, many vets and vet nurses have received little training on this sensitive topic.
"Understanding client's needs before, during and after euthanasia, helps staff establish a rapport with emotional clients at a critical time and maintains a positive practice image.
"The aim of the survey is to raise awareness among vets and vet nurses of the importance of feeling confident in their ability to help bereaved owners through their grief. This helps clients come to terms with the death of their pet enabling them to move on and welcome another companion animal into their lives."
To find out more about how CPC can help your practice to improve its bereavement care, please ring 01763 207700, email info@cpccares.com or visit www.cpcvets.com
The parasitologist Maggie Fisher is coordinating a survey across the UK on behalf of Bayer Healthcare, to test the efficacy of their flea treatment 'Advantage'.
She is looking to enlist some new practices to help her collect field strains of flea eggs in return for payment of £40 per sample.
If you are regularly seeing flea ridden cats or dogs and could help collect one or more samples of flea eggs by the end of November then please contact Jo Goodman on 01594 530809 or email her at Jo@ridgewayresearch.co.uk.
To apply for the VTS, you have to have to have been working in your speciality for a minimum of three years, and demonstrate 40-plus hours of RACE-approved CPD.
Before you can sit the exam, you also need to show that you already meet the required standards.
Emily said: “For the application itself, I had to demonstrate mastery of more than 40 advanced nursing skills, signed off by a neurology specialist, and submit three exam questions.
“I submitted more than 60 case logs demonstrating my nursing care in a variety of different patients and disease processes, and four of these logs I further expanded into 10-page case reports where I discussed the nursing care and disease process in more detail.
“Then, after submitting my application, there was a nerve-wracking wait for the results, but last December I received the news I had been accepted and I was invited to sit the examination in Philadelphia, USA, in June.
“The examination was four hours long and consisted of 200 questions in my specialty, and I’m really delighted I passed.
“Neurology is an area that can be quite niche and daunting to those unfamiliar with it, and I hope to use my new qualification to share my knowledge and enthusiasm with other professionals to help them feel more confident and comfortable with these patients.
“Personally, I find nursing neurologic patients extremely rewarding, as there is so much we can do as RVNs which has a direct impact on patient comfort, client understanding and, ultimately, on the clinical outcome.”
Asked why the CMA had decided to launch the review, its Senior Director for Consumer Protection told BBC R4's Today programme this morning that: "the costs of many vet services are rising higher than the cost of inflation, and it can be really hard to find out how much it's going to cost you, both for routine treatments or if something goes wrong and you need to find emergency care for your pet."
George added: "There's many other [veterinary] services and costs that people cannot have predicted and they can find themselves unexpectedly facing some really high bills, and when other household bills are going up very steeply at the moment we want to do everything we can to make sure that people can predict how much it is going to cost to see a vet, both for routine stuff but also for things if there's a crisis."
The authority is also looking at whether there is enough transparency over practice ownership.
With the percentage of independent practices falling from 89% in 2013 to 45% by 2021, the authority says people may not be clear if their vet is part of a group which owns other vet practices in their area or that the services which are being sold to them (such as diagnostic tests or treatments at a specialist animal hospital) are provided by that group.
This, it says, could impact pet owners’ choices and reduce the incentives of local vet practices to compete.
The CMA is now asking veterinary professionals, people who supply veterinary products and services and pet owners to take part in the review by completing an online questionnaire: https://www.gov.uk/guidance/how-to-respond-to-the-veterinary-services-market-for-pets-review
In particular, it wants to hear practitioners' experiences of:
The questionnaire will remain open for six weeks.
The CMA will outline the issues it identifies and announce its next steps early in 2024.
A survey carried out by Intervet/Schering-Plough Animal Health to launch Plerion, a chewable, flavoured wormer for dogs, has shown that most UK dog owners turn to their vet rather than a pet shop for advice on worming.
Over 83% of owners who took part in the survey said they follow their vet's advice on worming whilst fewer than 8% would follow the advice of their local pet shop. 63% choose to buy wormers from their vet against 35% buying wormers from a pet shop or online pharmacy.
Survey participants understood the importance of carrying out a regular worming programme with almost 80% stating that a dog should be wormed every three to four months. However, some owners cited forgetfulness as a reason for not worming their pet regularly and expressed a need for a reminder from their local vet practice.
Almost 85% of those who took part in the survey believed that not all wormers provide the same level of protection and almost 75% said that vet recommendation is the reason they purchase a specific brand of wormer. 94% of owners are aware that worms can affect people as well as dogs.
The survey revealed that 1 in 5 owners experienced difficulty in administering a complete dose due to their dog spitting out part or the entire tablet.
Intervet/Schering Plough says that Plerion should help reduce compliance issues; its innovative and tasty soft chew formulation meaning that most dogs will take it right out of the hand.
Sarah-Jane Minter, marketing manager at Intervet/Schering-Plough said: "When developing Plerion we knew it was essential to launch a product that made life easier for dog owners by being easy, and even fun, to administer as this would increase the likelihood of owners sticking to a regular worming programme. We are delighted by the feedback we are receiving from owners who report their once fussy dogs are taking the flavoured, chewable Plerion tablets as though they were treats."
Plerion is available in two tablet sizes that provide a combination of Pyrantel, Praziquantel and Oxantel which, the company says, gives effective treatment for the major endoparasites in a single dose including tapeworm Echinococcus multilocularis, as required by the Pets Travel Scheme (PETS).
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
Pooch & Mutt has 20x 40-day trials of its new joint & bone supplement, Mobile Bones Concentrate, to give away to veterinary professionals.
Guy Blaskey from Pooch & Mutt said: "At The London Vet Show vets and vet nurses told us that they loved the new Mobile Bones Concentrate because at just £9.99 per month it costs less than other joint supplements (whilst having the same high quality ingredients), it takes up a very small amount of shelf space and it doesn't involve the client having to either change their dog's food or stuff pills down their dog's throat."
In response to requests from vets and vet nurses to try the new joint supplement, Pooch & Mutt have set up a dedicated website at www.jointsupplementfordogs.com where you can apply from one of twenty 40 day trials.
Guy continued, "We did not want to simply send samples out to everyone. By setting up the site we can choose a variety of dogs from different breed and with different conditions to send a full 40-day trial to. We hope to get regular feedback from the vets, vet nurses and dog owners involved in the trial and publish it on http://www.jointsupplementfordogs.com/ for everyone else to see."
The trials are available to all veterinary professionals and can be for their own dogs, or dogs belonging to their clients.
Veterinary practices are being encouraged to enter the annual Veterinary Marketing Association's (VMA) awards, which now include a practice-only category.
The annual VMA awards are intended to recognise excellence in all aspects of veterinary and animal health marketing. The Practice Marketing Award, sponsored by Pfizer, is awarded to the companion or production animal practice that demonstrates the most initiative and innovation in the marketing of its products and/or services to end users. This can involve the use of any form of activity, including advertising, websites, direct mail and media relations.
Last year's winner of this award was Kessock Equine Vets from Aberdeen, who travelled down to London to receive their award at a presentation lunch. The 2009 awards presentation ceremony takes place on Friday, 19th March at the Old Brewery in Chiswell Street, London. The meeting also presents a very good opportunity for vets to meet representatives from all the major animal health companies.
Tickets for the event cost £115+VAT for VMA/VMPA members (£150+VAT for non-members). The price includes a three-course meal (prepared by a two-star Michelin chef) with wine, a champagne reception and entertainment by a top comedian.
Further information on the awards is available on the Veterinary Marketing Association's website - http://www.vma.org.uk/. Closing date for entries is 5th February 2010.
Eskimo, a reindeer at Edinburgh Zoo has received life-saving surgery just in time for Christmas, making him the first reindeer in history to receive keyhole surgery.
Vet Romain Pizzi successfully removed one of Eskimo's testes, which had been lodged in its abdomen since birth, using specialist surgical instruments donated to the zoo by one of Ark Surgical's strategic partners Surgical Innovations.
The zoo was worried that the retained testicle may have been developing into a tumour giving off abnormal hormones, and that this could become life-threatening. Thankfully, zoo surgeons found that the retained testicle, although abnormally sized, had not yet developed a tumour.
It is thought that the abnormal testicle was affecting Eskimo's production and flow of testosterone and, as a result, he was showing submissive behaviour and being bullied by the other male reindeer in the herd. He had also started to show some abnormal and delayed antler growth and development. Removing the testicle will halt any abnormal hormone production so hopefully Eskimo will return to full vigour just in time for Christmas.
Gavin O'Brien, Director at Ark Surgical said: "We were only too happy to help when Romain mentioned the challenging operation faced by Eskimo and in the season of goodwill we approached Surgical Innovations who kindly donated the instruments for this pioneering surgery."
Although laparoscopic surgery is routine in humans, the standard procedure in animals is still open abdominal surgery. Open abdominal surgery is 20 years behind human medical advances and has a number of negative factors on animals such as more post-operative pain, slower recovery and a higher risk of post-operative complications and infections.
Romain, a veterinary surgeon for the Royal Zoological Society of Scotland, based at Edinburgh Zoo, said: "Laparoscopic surgery is still very uncommon in veterinary medicine, even amongst common species such as dogs, cats and horses, so for keyhole surgery to be carried out on a reindeer shows a great advancement in veterinary surgery."
It is estimated that nearly one out of every two households in the UK are pet owners. Veterinary surgeons perform on average 600,000 open abdominal procedures annually but it is believed that less than 1% of vets currently practice laparoscopic surgery.
Romain believes that with the right instrumentation available through innovative companies such as Ark Surgical, UK vets now have more opportunity than ever to introduce laparoscopic techniques as part of their operating procedures.
Romain said: "This procedure was only really possible thanks to a cutting-edge designed retractor which we were able to use in this case. Ironically although a reindeer is a reasonably large animal, due to their unique anatomy and massive four chambered stomach that takes up most of the space in the abdomen, there is a very limited internal operating space. For this reason the operation was much more difficult than in a human, or in a dog, where there is more space to work, despite their smaller size."
"We were especially pleased with how quickly Eskimo recovered after surgery, he was standing and happily eating lichen again within 10 minutes of recovery from anaesthesia. He hardly seemed to notice he had even had surgery, although he was still slightly groggy from the anaesthesia. This would simply not have been possible with traditional open abdominal surgery, as the long wound would have been much more painful and debilitating."
The minimally invasive nature of laparoscopic surgery means there are numerous benefits for animals such as a reduction in post-operative pain, a faster recovery and reduced post-operative care. It also has a decreased risk of infection after surgery and a lower risk of any wound complications.
For veterinary surgeons laparoscopic surgery can offer better visualisation of the operated area, allowing them to be more precise and reach areas that are difficult to see in open surgery such as the liver and pelvic canal.
Romain carries out laparoscopic operations on dogs, cats and exotic pets at his own veterinary practice Inglis Veterinary Centre (Scotland) and has pioneered several new laparoscopic techniques.
He said: "Laparoscopic surgery has so many benefits for the animal, the veterinary surgeons and the zoo, so there is no reason why it should not be more common practice within veterinary surgery. I hope Eskimo's experience helps raise its profile and encourage more veterinary surgeons to look in to it as a standard surgical procedure."
Ark Surgical offers a wide range of laparoscopy instruments and peripherals to vets across the UK and to suit all budgets. The company says it is already working with many of the UK's leading vets and agencies such as the Royal Zoological Society of Scotland, as well as the UK foremost laparoscopic medical device manufacturer Surgical Innovations, to be at the forefront of veterinary laparoscopic surgery
For more information on animal laparoscopic surgery contact Ark Surgical on 01732 862882 or http://www.arksurgical.co.uk/
The RCVS Trust will take part in National Pet Month (3 April - 3 May) and is asking veterinary practices to put on 'Alice in Wonderland' themed fundraising events.
Cherry Bushell, RCVS Trust Director said: "The Trust aims to improve the health and well-being of dogs, cats, and other popular household pets and over the past five years has put nearly £900,000 into this cause. As a small charity we do rely on our supporters - and National Pet Month is a good opportunity to raise money and have fun."
Why Alice in Wonderland as a theme? Cherry said: "The Trust supports curiosity and a sense of wonder, so we came up with the Alice in Wonderland idea - which is topical and also has lots of scope for fundraising and publicity."
If you'd enjoy hosting a Mad Hatter's tea party - or raffling off the Queen of Heart's tarts - you can register with National Pet Month and take part. Further information and a free events pack can be obtained from http://www.nationalpetmonth.org.uk/.
National Pet Month runs from 3 April - 3 May. It aims to promote responsible pet ownership, make people aware of the mutual benefits of living with pets, increase public awareness of the role of pet care specialists and raise awareness of the value of working and assistance companion animals.
Rabbit Awareness Week (26th April - 2nd May 2010) is reportedly going to be bigger than ever this year with over 1000 vets within the industry expected to be involved.
In partnership with Burgess Pet Care, Petplan Insurance, Company of Animals, Intervet/Schering-Plough Animal Health, Genitrix, PDSA, Wood Green Animal Shelters and RWAF, Rabbit Awareness Week's mission is to educate current and potential rabbit owners across the UK about the importance of rabbit welfare.
The focus of the week will be rabbit obesity. At the same time, organisers hope the week will raise the profile of rabbits as pets and encourage owners to seek the right veterinary advice about rabbit nutrition and health.
The week has been deliberately timed to happen soon after Easter, to make use of a time of year when rabbits are at the forefront of people's minds. Organisers hope to reach rabbit owners who may have bought new pet rabbits but who may not have the right information about how to keep them happy and healthy.
Throughout the week some of the UK's largest retailers, suppliers of rabbit food and welfare charities will be providing valuable feeding knowledge and information, along with a range of deals and offers to vets and pet owners.
Organisers are asking veterinary practices to get involved by offering Free Health Checks for pet rabbits, and by providing free advice about vaccinations, husbandry and diet. To help, there is a range of display and training materials to help you run your Free Health Checks together with promotional materials such as newsletter templates and press releases. You can also register your event for free on the Online Event Locator.
The display kit includes shelf wobblers, barkers, posters, appointment flyers, Health Check Certificates and an A3 size Free Health Check window sticker. You'll also receive additional items to give away to rabbit owners, including Excel samples, RAW care guides, car stickers and branded bags.
For more information and to find out what special trade offers are available to vets during the week register at http://www.rabbitawarenessweek.co.uk/.
Novartis Animal Health has launched a chewable formulation of Milbemax wormer, for dogs.
According to the company, clinical studies have shown that the chicken-flavoured formulation and chewy texture of Milbemax Chewable Tablets is highly palatable, with more than 94% of dogs showing spontaneous acceptance from hand. Novartis says this should help make worming simpler and improve compliance, something which is particularly important given market research which shows that difficulties in administering medications often leads to missed treatments.
Containing milbemycin oxime and praziquantel, the new tablets deliver the same broad spectrum efficacy as existing Milbemax formulations, effective for the treatment of roundworm, hookworm, whipworm, lungworm and tapeworm, and for the prevention of heartworm.
Folkert Kamphuis, Chief Operating Officer at Novartis Animal Health said: "The new EASYCHEW™ formulation represents Novartis Animal Health's latest innovation. It will make worming a treat whilst providing tried-and-trusted Milbemax efficacy. With Milbemax chewable tablets we give pet owners a wormer that is easy to administer and veterinarians the trusted efficacy of Milbemax."
Milbemax Chewable Tablets are available for both dogs and puppies, in four and forty-eight tablet packs.
Novartis Animal Health's year long campaign to drive pet-owner awareness of the importance of worming pets regularly got off to a rather damp start in London today, with 63 people in doggy suits - mostly company employees I gather - running around the capital accompanied by two 'pooch vans'.
The 'Worm Patrol' team will be visiting veterinary practices over the summer to help promote, set up and run Pet Worming Awareness Days and attend practice open days. Veterinary practitioners will have access to the Worm Patrol support kit including the branded pooch van, Chewy the dog mascot and a worm patrol ambassador. Additional support will include educational leaflets for owners, giveaways and waiting room materials.
Maggie Fisher, Chairperson of the European Scientific Counsel for Companion Animal Parasites is backing the campaign. She said: "Raising awareness of worm control throughout the life of cats and dogs is important, particularly when it is reported that 80 percent of children kiss their pet and 21 percent let them lick their fingers after sharing food. While the risk may be relatively low, the consequences can be serious, especially in children.
"It's important that pet owners take responsibility for their animals and we are pleased that initiatives such as the Worm Patrol and 'Pet Worming Awareness Days' will help practices highlight the risk that endoparasites pose to humans and companion animals in a novel and light-hearted way."
To arrange for the Worm Patrol to visit to your practice, or for further information about setting up a Pet Awareness Worming Day, please contact your Novartis Animal Health Territory Manager or Novartis Animal Health UK Ltd on +44 (0)1276 694402.
The RCVS is to embark on a communications campaign over the next few months to raise awareness amongst the general public of the difficulties that vets face in providing out-of-hours emergency cover, and the responsibilities incumbent on animal owners to know what to do in a veterinary emergency.
Emergency cover has been high on the College's agenda for some time.
Over the last 18 months, the RCVS 24/7 Working Party has considered the ongoing desire of vets to continue to offer emergency care 24 hours a day, and the feasibility of delivering this, against a backdrop of the Working Time Regulations, geographical variations in animal and vet density, and increasing practice diversity.
Working Party meetings have been supported by a survey of how vets are currently meeting their 24/7 requirements, a seminar of stakeholders and regular informal polls at RCVS Question Time meetings.
It was agreed at the September 2009 meeting of Advisory Committee, to which the Working Party reports, that the majority of vets remain willing to deliver emergency cover 24/7. Advisory Committee recommended that a communications project be undertaken to help raise awareness amongst the general public and animal owners that although the veterinary profession continues to make this voluntary commitment, EU rules, geography and financial constraints impose some limitations.
This campaign will kick off soon and focus on spreading messages via animal-owner publications and websites. The responsibility of pet owners to know how they can access emergency care for their animal in advance of need will be stressed, as will the fact that in the absence of an NHS for pets, emergency care is a service for which practices must charge a realistic fee (which is likely to be higher than for day-time work).
The campaign will also outline vets' responsibilities as part of the Guide, so the public knows what it can reasonably expect. It would be helpful if practices could ensure they have clear information available on their 24/7 arrangements - as outlined in the Guide - should this campaign stimulate requests from clients.
Jerry Davies, who chaired the Working Party, said: "There is overwhelming opinion within the profession that we must continue to provide round-the-clock veterinary care. The main tenet of the Working Time Regulations is that workers should not have their health or, importantly, skills compromised by unreasonable working patterns. Vets, VNs and the animals they care for deserve the same level of protection.
"However, this legislation has made continuing to provide such care at a reasonable cost to the animal owner a significant challenge. Meeting this challenge will require the understanding and cooperation of the animal owning public.
"If clients can be flexible and accept slightly longer response times, an effective service can still be sustained. The key is for all animal owners to establish, in advance, exactly what will be involved should they need to access veterinary care in an emergency. This simple step will help optimise response times and eliminate the frustration, confusion and inevitable dissatisfaction that may arise if ill-prepared."
Hill's Pet Nutrition has highlighted recent studies which, the company says, prove that feeding a food enriched with omega-3 fatty acids from fish oils to dogs with osteoarthritis results in a reduction in NSAID dosage of up to 25%1, owner observed improvements in clinical signs3, and improved weight bearing ability2, 7
The claim that food can effectively support medical treatment follows in the wake of two published and one in press study in the Journal of the American Veterinary Medicine Association (JAVMA). These demonstrate that omega-3 enriched food (in this case Hill's Prescription Diet j/d Canine) has significant effects on weight bearing and helps reduce NSAID dosage by up to 25 per cent, when fed to dogs with osteoarthritis 1, 2,3.
According to Hill's, the research demonstrates that in dogs the high levels of eicosapentaenoic acid (EPA) from fish oils can down-regulate the cartilage degrading enzyme aggrecanase1. In vitro studies have also identified that EPA resulted in a reduction in the amount of degraded cartilage residue produced4. High levels of omega-3 fatty acids can also help to reduce inflammation5,6.
The two studies that were recently published confirm that feeding a diet rich in omega-3 fatty acids aids in the management of osteoarthritis in dogs2,3. The randomized double-blinded controlled trials were carried out over three and six months respectively and involved a total of 165 dogs identified as suffering from mild to moderate osteoarthritis. After collating the results from almost 25,000 trial days, researchers were able to confirm a significant 'clinical improvement' from feeding a food fortified with fatty acids.
In the first study described in JAVMA, researchers found evidence that omega-3 fatty acids from fish oils resulted in improvements in weight bearing2. Objective measurement using force plate gait analysis demonstrated that dogs fed a test food fortified with fatty acids were seven times as likely to show improved weight bearing compared with dogs fed a control food.
In the second study, through a detailed questionnaire, owners also observed significant improvements in their dog's osteoarthritic condition3. Improvements observed covered the following signs: difficulty in rising from rest, limping, stiffness, soreness when touched, yelping or whimpering in pain, aggression, lagging on walks, reluctance to play and overall activity level.
Adrian Pratt, Veterinary Affairs Manager for Hill's Pet Nutrition, manufacturer of Prescription Diet j/d, which is enriched with omega-3 fatty acids, hailed the results as a breakthrough in the field of nutrigenomics (the study of the effects of nutrition on gene expression): "This research points the way to a new model for the management of osteoarthritis, using a clinically proven food to interrupt the cycle of damage and cartilage degradation, alongside graded levels of NSAIDs and proactive programmes to manage weight and adjust exercise routines. Clinicians now have the conclusive proof they need to recommend feeding omega-3 enriched food to ameliorate the signs of osteoarthritis in clients' pets and to adjust NSAID doses accordingly."
For further information on Hill's Prescription Diet j/d, please contact your Hill's Territory Manager or call 0800 282438.
References1. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega-3 fatty acids on the Carpofen dosage in dogs with osteoarthritis. Fritsch A, Allen T, Dodd C, JAVMA in press2. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs. Roush J, Cross A, Renberg W, Dodd C, Sixby K, Fritsch A, Allen T, Jewell, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp67-733. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Roush J, Dodd C, Fritsch A, Allen T, Jewell D, Schoenherr W, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp 59-664. Eicosapentaenoate supplementation abrogates canine articular cartilage degeneration in in vitro explant culture systems, Caterson B, Cramp J, Little C B et al, Hills European Symposium on osteoarthritis and joint health 2005 14-195. Dietary modification of inflammation with lipids, P C Calder, Proceedings of the Nutrition Society 2002 345-3586. Dietary polyunsaturated fatty acids and inflammatory mediator production, James M J, Cleland L G, Gibson R A, Am J Clin Nut 2000: 71 suppl 343S- 358S7. Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995; 206 (6): 807-811.
The CVS practice aimed to change its prescribing culture by adopting an evidence-based, case-by-case approach and supporting its vets in only using antibiotics where absolutely necessary.
The practice identified the use of antibiotics in the treatment of cat bite abscesses (CBAs) as worthy of investigation.
Cefovecin, a third-generation cephalosporin and critically important antibiotic, is often used in the treatment of CBAs.
The practice first sought guidance from a dermatology specialist with an active research programme involving the study of antimicrobial resistance (AMR).
It then developed a clinical guideline advising that if a cat has a discrete abscess, with no pyrexia (raised temperature) and no cellulitis, antibiotics are not required.
White Lodge then conducted an eight-month clinical audit across its Exmouth Hub, with the aim of measuring the effect of the new guideline.
The practice treated patients with CBA’s with NSAIDS, lancing and flushing (if necessary), and cleaning of the abscess.
Owners were advised to flush the affected area at home once daily.
An antibiotic awareness leaflet was given to clients with an explanation of the reasoning behind not prescribing antibiotics.
Cats presented 5-7 days after treatment for a nurse re-examination.
A consultation template was created for both the vet at initial presentation and another for the nurse’s post treatment check, to gather standardised information.
The measure of successful treatment was whether, on re-examination, the CBA site appeared free from infection and wound healing was evident.
If the wound had not started to heal or if there was infection or pyrexia, the treatment was deemed to have failed and further treatment was provided.
Analysis of the results showed that of the 22 cats included in the audit, 19 (86%) did not need antibiotics to successfully treat the abscess.
There was also a 32.6% reduction in the number of times cefovecin was dispensed in the eight-month period after the audit started, compared with the previous eight months.
Emily Parr, Head Veterinary Surgeon at White Lodge, said: “We think, due to lack of confidence in treatment without antibiotics as well as client pressure or expectation, the profession tends to default to the prescribing of antibiotics.
“However, this clinical audit has given our veterinary colleagues increased confidence in treating CBA’s without antibiotics.
"There has also been an improved client understanding in accepting treatment without antibiotics.
"Clients have also been positive when minimal intervention has been required, particularly as it eliminates the cost of antibiotics.
"This has had a positive impact on the vet-client relationship and trust in our practice.
“Antimicrobial resistance is continuing to threaten the efficacy and treatment of an ever-increasing range of infections.
"So we hope that our CBA clinical audit outcome results will help to set a benchmark and shape clinical guidelines for the wider veterinary profession in this area.”
Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy.
Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides. It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the product has been extensively and independently trialled, proven to be efficacious without adverse reactions, and that the necessary pharmacovigilance is in place to support it.
The company also says that the availability of a licensed product paves the way for more comprehensive information to be provided to veterinary surgeons on the use of potassium bromide in treating seizures. The Veterinary Medicines Directorate (VMD) imposes restrictions on educational materials supplied by manufacturers of unlicensed products, an approach which has created a 'knowledge gap' among many veterinary surgeons in general practice, according to some canine epilepsy experts.
Libromide tablets are intended for use in epileptic dogs which have already commenced therapy with Phenobarbital. Phenobarbital acts to increase the effects of the GABA inhibitory neurotransmitter in the central nervous system. Potassium bromide is synergistic with Phenobarbital and raises the seizure threshold level in epileptic dogs.
Libromide is classified as POM-V and will be available in 325 mg tablets in packs of 100 and 500 tablets.
Rodolfo Cappello DVM PhD DipECVN MRCVS, RCVS and European Specialist in Neurology and Neurosurgery, Head of Neurology Services at North Downs Specialist Referrals, Surrey, said: "I've been successfully using potassium bromide for the treatment of epilepsy in dogs for over 15 years. The main problem has been that it's not been licensed as a medicine. With the launch of Libromide, potassium bromide finally achieves the status of an approved pharmaceutical. We will now be able to monitor quality, efficacy and side effects which will enable us to offer a more professional approach to the treatment of seizures."
Howard Wilder, founder and managing director of Genitrix, added: "Canine epilepsy is an all too common disease with estimates suggesting it affects four in every hundred dogs in the UK. It's also an illness which is not well enough understood with the lack of up to date information available to veterinary surgeons being a contributing factor.
We felt there was an opportunity to bring a licensed product to market and have invested hundreds of thousands of pounds in the process of development and trialling Libromide. We're delighted to make it available to veterinary professionals and hope its launch will be the first step in improving treatment approaches for this distressing disease."
Broadline was a fipronil-based parasiticide which also contained (S)-methoprene, eprinomectin and praziquantel.
NexGard Combo, on the other hand, contains esafoxolaner together with eprinomectin and praziquantel for worming.
Both products are licensed for use in cats with or at risk from mixed infestations by fleas, ticks, mites cestodes, nematodes.
There's an explainer video about NexGard Combo on the Boehringer Academy website: https://www.boehringer-academy.co.uk/
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
Each year the WSAVA Congress is held in a different location around the world and attracts over 70,000 veterinary professionals who relish the opportunity to hear from top international speakers on all aspects of practicing small animal veterinary medicine.
The WSAVA is an international network of associations dedicated to the continuing development of companion animal care around the world. It brings veterinary practitioners and academia together to help enhance the knowledge of specific topics, such as hereditary disease and nomenclature of pathological processes.
To celebrate the Association's 50th anniversary Professor Michael J Day, chairman of the WSAVA Scientific Advisory Committee, has proposed that this year be the year of 'One Medicine'. The theme is intended to recognise the importance of the link between the medical and veterinary professions. It will encompass the human population, domestic animals and wildlife, and the impact that current environmental changes are having on these groups. Lectures and seminars during this year's congress will reflect the 'One Medicine' topic, looking for an exchange of ideas and to build the foundations for future developments of mutual interest. For further information please visit http://www.wsava2010.org/.
Veterinary staff can enter the WSAVA prize draw by visiting Petplan at stand 311 during the BSAVA Congress or via the dedicated Petplan veterinary staff website, petplanvet.co.uk.
Dogs Trust has come out firmly against RSPCA-supported proposals to re-introduce the dog licence.
The dog welfare charity says it does not believe re-introducing the dog licence would provide a welfare benefit for dogs. It has also expressed surprise at the RSPCA position, which is that: "a licence would be hugely beneficial in addressing many animal welfare concerns stemming from overbreeding of dogs to a lack of traceable ownership." Dogs Trust has said this view is extremely naïve, that responsible owners might struggle to pay what is likely to be a punitive annual licence, and that a licence is simply a tax on dog ownership.
Meanwhile, the RSPCA has announced the results of a survey in which 2 out of 3 pet owners said they would be in favour of a licence scheme. 76% said that a dog licence should be enforced in England to help curb problems such as 'puppy farms', stray dogs, stolen dogs and animal abandonments.
The RSPCA also says that research carried out on its behalf by Reading University clearly shows that an affordable and well-enforced dog licensing scheme could provide funding for a range of issues, most of which are currently funded poorly by central and local government. Professor Emeritus Martin Upton from Reading University's school of agriculture, policy and development, said: "Our study into the potential costs and benefits of dog licencing and registration found that such a scheme could greatly contribute to responsible dog ownership and animal welfare."
Dogs Trust says the dog licence has been shown to be an ineffective measure in the UK. In Northern Ireland, where the dog licence is still a requirement, only an estimated one-third of all dog owners currently have their dogs licensed. Northern Ireland still has the highest number of stray dogs per head of population of any region in the UK and the number of dogs put to sleep in the region represents a staggering 34% of the total UK figure.
The charity recommends compulsory microchipping as the most effective means of registration as well as identification of a dog. Unlike the dog licence, which involves an annual fee, microchipping involves just a small one-off fee (Dogs Trust offers microchipping at its centres for £10). The benefit to responsible owners and their dogs is therefore relatively cheap and effective. Microchipping a dog should infer legal ownership and reinforces the responsibilities of the owner under the Animal Welfare Act. The introduction of compulsory microchipping would allow stray dogs to be quickly returned to their owners, make easier the identification of owners who persistently allow their dogs to stray or cause nuisance, and make all puppies traceable to their breeder, helping to reduce the widespread problem of battery farming of dogs.
US company Midmark is running a UK prize draw to win a Cardell 9401 blood pressure monitor worth nearly £2000.
To enter the draw, click here.
Vygon Vet, a division of Vygon (UK) Ltd, has announced the launch of its website - www.vygonvet.co.uk.
Vygon has been supplying the veterinary market for 15 years. The new website means the company's products can now be bought direct online. The range includes: Vascular Access, IV Management, Needle-Free Devices, Respiratory, Digestive Tract, Regional Anaesthesia, Tissue Adhesive, Urinary & Rectal Tract and Theatre Products.
In addition to product information and technical data, the website offers guidance notes and tips about basic procedures.
Les Davies, Managing Director of Vygon (UK) Ltd said: "The launch of the new website demonstrates our commitment to the veterinary market and we hope that it not only enables veterinary professionals to order our products with ease, but that they also find the guidance notes and advice a valuable resource for their practice."
Vygon Vet products can also be ordered by telephone or through your veterinary wholesaler.
Bayer Animal Health, manufacturer of Advocate, is launching an advertising campaign to support its 'Be Lungworm Aware' initiative, which aims to educate pet owners on the spread of Angiostrongylus vasorum and encourage them to seek advice from their local veterinary practice.
The campaign will see a new TV 'public information' style advertisement targeting dog owners. It will air on 20 national TV channels during April including ITV1, 2 and 3, Sky 1, 2 and 3, More 4 and Film4, with air time dedicated to GMTV and daytime ITV.
The TV advertising campaign will focus on the parasite's intermediate hosts - slugs and snails - and the ease in which dogs can become infected with the parasite by picking up something as simple as a toy with a slug attached to it.
Print advertisements will also be running in national newspapers and women's consumer magazines with a focus on publications read by pet owners.
Marketing support material is available for veterinary practices wishing to participate in the 'Be Lungworm Aware' initiative. For further details, or to order the new practice materials, please contact your Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.
CEVA Animal Health has updated its practice support materials to include an all-encompassing D.A.P. client leaflet, a website and a new vet detailer.
The new materials, which also include a D.A.P. and Feliway reference guide containing details of 31 published trials into the practical applications of pheromones, focus on using D.A.P. to prevent stress at key stages of a dog's life. Particular attention is paid to the benefits of fitting a D.A.P. Collar during early puppy consults in order to help prepare dogs for the modern world and helping to prevent anxiety-related problems such as separation anxiety and noise phobia, developing in later life. In addition, the vet brochure will draw practitioners' attention to the times in a dog's life when owners are particularly concerned about their dog becoming stressed including events like trips to boarding kennels.
Lucy Brett, product manager at CEVA Animal Health, said: "Over the last three years eight different trials have been published looking at the use of pheromones to reduce canine stress. The latest data backs up what we have believed for some time - that the management of stress during socialisation is vital if dogs are to grow into emotionally balanced and confident adult dogs. We now have a much better idea of the impact of allowing puppies to get stressed or overwhelmed during socialisation and the difference providing pheromone support in the form of a D.A.P. Collar can make."
For further details, or for information on CEVA's range of educational resources for veterinary professionals interested in feline and canine behaviour, please contact your CEVA Animal Health representative or call 01494 781510.
The company points to research which showed that 42% of cats and 28% of dogs have lesions which are only detectable on x-ray1.
Failing to identify teeth with root lesions can have a significant impact on patient welfare, causing ongoing pain and eventual tooth loss.
The first priority for the CVS clinical improvement project was to review how effective its first opinion small animal practices were at using radiography in dental examinations.
In July 2021, only 16.2% of dental cases had radiography performed and clinicians were mostly using visual examination to guide decision making.
The project then identified the barriers to using dental radiography as: a lack of dental radiography equipment in a practice, a lack of clinician confidence in taking and interpreting the radiographs and a belief that pet owners would not want to pay for it.
To address the first issue, CVS installed new dental radiography machines at over 104 sites, at a cost of £615,000 over the course of the year.
The company then upskilled its vets and nurses in dental radiography - looking specifically at getting good quality radiographs and interpretation.
Finally, the company conducted an audit of each participating practice’s dental radiology data, updating it each month and sharing the results with the practices..
One year on, CVS says the data shows that 43% of dental cases in project practices are now using dental radiography as part of their consultation.
In the best cases, some practices have been using radiography in 100% of cases.
Hub Clinical Lead Deborah Komianos said: “When you open a patient’s mouth and look inside, seemingly normal teeth are oftentimes not normal.
"So vets and nurses can risk missing periodontal disease.
“Dental radiology has historically been underutilised but we believe it adds valuable information to dental consultations and is an important decision-making tool.
“We’re thrilled with the early results in our practices.
"It shows there’s been a real change of mind-set and behaviour towards using X-rays in dentistry – as well as increased confidence in execution."
Reference